Increasingly selective pharmacologic targets in cardiovascular disease Rodolfo PaolettiAndrea Cignarella Invited Commentary 26 April 2007 Pages: 89 - 90
Web alert Robert Chilton, DO Department of Veterans Affairs, Audie L. Murphy Veterans Hospital, 7400 Merton Minter, San Antonio, TX 78284, USA E-mail: chilton@uthscsa.edu EditorialNotes 26 April 2007 Pages: 91 - 91
The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis Salim S. ViraniVijay Nambi OriginalPaper 26 April 2007 Pages: 97 - 103
Immunization for atherosclerosis Kuang-Yuh ChyuJan NilssonPrediman K. Shah OriginalPaper 26 April 2007 Pages: 104 - 109
The role of hypertriglyceridemia in atherosclerosis Ngoc-Anh LeMary F. Walter OriginalPaper 26 April 2007 Pages: 110 - 115
Alcohol and atherosclerosis: Recent insights Janne TolstrupMorten Grønbaek OriginalPaper 26 April 2007 Pages: 116 - 124
The role of CETP inhibition in dyslipidemia Karim El HarchaouiWim A. van der SteegJohn J. P. Kastelein OriginalPaper Open access 26 April 2007 Pages: 125 - 133
Obesity and inflammation: A new look at an old problem Sachin MehtaJohn A. Farmer OriginalPaper 26 April 2007 Pages: 134 - 138
Arterial stiffness as a risk factor for coronary atherosclerosis Daniel A. DuprezJay N. Cohn OriginalPaper 26 April 2007 Pages: 139 - 144
Beyond lipids: The role of omega-3 fatty acids from fish oil in the prevention of coronary heart disease Terry A. Jacobson OriginalPaper 26 April 2007 Pages: 145 - 153
Diabetic dyslipidemia and atherosclerosis: Evidence from clinical trials John A. Farmer OriginalPaper 26 April 2007 Pages: 162 - 168